NEW YORK (Reuters Health) – When asymptomatic patients with a supratherapeutic INR are seen in the emergency department, can they be treated as outpatients or should they be…
NEW Y ORK (Reuters Health) – For patients with rheumatoid arthritis, the selective T-cell co-stimulation modulator abatacept works just as well whether administered subcutaneously (SC) once a week…
NEW YORK (Reuters Health) – In a small preliminary study, a combination pill containing 85 milligrams of sumatriptan and 500 milligrams of naproxen sodium formulated in a rapid…
NEW YORK (Reuters Health) – Patients with moderate-to-severe chronic obstructive pulmonary disease have a greater improvement in dyspnea and health status after 12 weeks of treatment with inhaled…
NEW YORK (Reuters Health) – Subcutaneous immunotherapy is at least as effective as drug therapy in controlling symptoms of seasonal allergic rhinitis, even in the first season after…
NEW YORK (Reuters Health) – Patients with hypercholesterolemia who do not reach target lipid levels with rosuvastatin have a better change of reaching their goals by adding ezetimibe…
NEW YORK (Reuters Health) – In adults with overactive bladder and nocturia, treatment with solifenacin, may improve quality of sleep and sleep-related quality of life by decreasing the…
NEW YORK (Reuters Health) – Results of a Mexican study indicate that 2 months of treatment with the antiinflammatory agent diacerein increases insulin secretion and improves A1C levels…
NEW YORK (Reuters Health) – The excess risk of unexplained sudden death in psychiatric patients may be related to diabetes and dyslipidemia rather than to the antipsychotic drugs…
NEW YORK (Reuters Health) – The longitudinal decline in lung function seen in patients with common variable immunodeficiency and X-linked agammaglobulinemia is related to immunoglobulin replacement level and…